Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs remimazolam for sedation during painless bronchoscopy
ChiCTR2400092527Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in procedure-related pain and discomfort during fiberoptic bronchoscopy comparing Ciprofol + sufentanil with Remimazolam + sufentanil (2 arms). Primary endpoint: Sedation success rate. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
ciprofolremimazolam
03
Conditions
procedure-related pain and discomfort during fiberoptic bronchoscopy
Beyond the preview
Go deeper on ChiCTR2400092527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092527.